Targeted Medical Pharma, Inc. (TRGM)
OTCMKTS · Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
At close: Nov 12, 2025
Targeted Medical Pharma Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2015 | FY 2014 | FY 2013 | FY 2012 | FY 2011 | 2008 - 2010 |
|---|---|---|---|---|---|---|
Period Ending | Dec '15 Dec 31, 2015 | Dec '14 Dec 31, 2014 | Dec '13 Dec 31, 2013 | Dec '12 Dec 31, 2012 | Dec '11 Dec 31, 2011 | 2008 - 2010 |
Cash & Equivalents | 0.08 | 0.01 | 0.49 | 0.33 | 0.15 | Upgrade |
Cash & Short-Term Investments | 0.08 | 0.01 | 0.49 | 0.33 | 0.15 | Upgrade |
Cash Growth | 604.00% | -97.61% | 50.58% | 121.63% | -85.83% | Upgrade |
Accounts Receivable | 0.33 | 0.2 | 0.27 | 0.35 | 0.9 | Upgrade |
Other Receivables | 0.14 | 0.04 | - | - | - | Upgrade |
Receivables | 0.47 | 0.24 | 0.27 | 0.35 | 0.92 | Upgrade |
Inventory | 0.09 | 0.13 | 0.6 | 0.48 | 0.5 | Upgrade |
Prepaid Expenses | 0.11 | 0.12 | - | - | 1.03 | Upgrade |
Other Current Assets | 0.08 | 0.03 | 1.27 | 1.12 | - | Upgrade |
Total Current Assets | 0.83 | 0.53 | 2.63 | 2.53 | 2.9 | Upgrade |
Property, Plant & Equipment | 0.05 | 0.11 | 0.24 | 0.34 | 0.41 | Upgrade |
Other Intangible Assets | 1.54 | 1.86 | 2.13 | 2.32 | 2.39 | Upgrade |
Long-Term Deferred Tax Assets | - | - | - | 5.41 | 3.14 | Upgrade |
Other Long-Term Assets | - | - | - | 0.03 | 0.14 | Upgrade |
Total Assets | 2.43 | 2.5 | 5 | 10.63 | 8.98 | Upgrade |
Accounts Payable | 1.86 | 1.46 | 1.5 | 2.16 | 5.04 | Upgrade |
Accrued Expenses | 4.98 | 4.61 | 3.07 | 2.31 | - | Upgrade |
Short-Term Debt | 2.5 | 2.5 | 2.62 | 5.03 | 2.38 | Upgrade |
Current Portion of Long-Term Debt | 2.12 | 1.09 | 1.46 | - | - | Upgrade |
Other Current Liabilities | 3.21 | 2.68 | 2.61 | 2.74 | - | Upgrade |
Total Current Liabilities | 14.68 | 12.35 | 11.26 | 12.25 | 7.48 | Upgrade |
Long-Term Debt | 0.67 | 0.12 | 0.75 | 0.39 | - | Upgrade |
Long-Term Deferred Tax Liabilities | - | - | - | - | 0.89 | Upgrade |
Total Liabilities | 15.35 | 12.47 | 12.02 | 12.63 | 8.37 | Upgrade |
Common Stock | 0.03 | 0.03 | 0.03 | 0.02 | 0.02 | Upgrade |
Additional Paid-In Capital | 17.04 | 16.92 | 15.98 | 11.66 | 4.68 | Upgrade |
Retained Earnings | -29.96 | -26.92 | -23.02 | -13.68 | -4.1 | Upgrade |
Total Common Equity | -12.9 | -9.97 | -7.02 | -2 | 0.61 | Upgrade |
Minority Interest | -0.02 | - | - | - | - | Upgrade |
Shareholders' Equity | -12.92 | -9.97 | -7.02 | -2 | 0.61 | Upgrade |
Total Liabilities & Equity | 2.43 | 2.5 | 5 | 10.63 | 8.98 | Upgrade |
Total Debt | 5.29 | 3.72 | 4.83 | 5.42 | 2.38 | Upgrade |
Net Cash (Debt) | -5.21 | -3.71 | -4.34 | -5.09 | -2.23 | Upgrade |
Net Cash Per Share | -0.19 | -0.14 | -0.18 | -0.23 | -0.10 | Upgrade |
Filing Date Shares Outstanding | 30.19 | 26.77 | 25.74 | 23.01 | 21.95 | Upgrade |
Total Common Shares Outstanding | 27.73 | 26.77 | 25.74 | 23.01 | 21.95 | Upgrade |
Working Capital | -13.84 | -11.82 | -8.63 | -9.72 | -4.58 | Upgrade |
Book Value Per Share | -0.47 | -0.37 | -0.27 | -0.09 | 0.03 | Upgrade |
Tangible Book Value | -14.44 | -11.83 | -9.15 | -4.32 | -1.78 | Upgrade |
Tangible Book Value Per Share | -0.52 | -0.44 | -0.36 | -0.19 | -0.08 | Upgrade |
Machinery | 0.48 | 0.83 | 0.96 | 0.92 | 0.83 | Upgrade |
Leasehold Improvements | 0.11 | 0.25 | 0.25 | 0.25 | 0.23 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.